Pure Leaf Iced Tea Sweet Tea (Lipton) – Consumer Complaint (2014)
Class II: A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Class II recall indicates potential for temporary health effects.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Lipton Pure Leaf Iced Tea Sweet Tea 18.5OZ PL 6 Pack
Brand
Pepsi Beverages Company
Lot Codes / Batch Numbers
Not specified in FDA notice. Check official source for details.
Products Sold
Item # 133245 (6 pk) with codes: XXXXGG03064 Manufactured on: 03/06/14 BTL: Oct 06 14 Code Interpretation as follows: OCT 06 14 XXXXGG03034 Where: OCT 06 14 = End Date XXXX= Military Time (0000-2359) GG = Plt. Designator 03034= Prod Date (03/03/14)
Pepsi Beverages Company is recalling Lipton Pure Leaf Iced Tea Sweet Tea 18.5OZ PL 6 Pack due to Pepsi Co has announced a recall of some Lipton Pure Leaf Iced Tea products produced on March 3, 4, 5, and 6th of 2014 due to recent consumer complaint. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Pepsi Co has announced a recall of some Lipton Pure Leaf Iced Tea products produced on March 3, 4, 5, and 6th of 2014 due to recent consumer complaints regarding apparent mold in the product.
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticeDistribution
As reported by FDA
DE, IL, IN, IA, KY, MD, MN, MO, NJ, NY, OH, PA, SD, TN, VA, WI
Page updated: Jan 6, 2026